MindUP Invests in its 13th Portfolio Company: CogMe, a Holis

MindUP Invests in its 13th Portfolio Company: CogMe, a Holistic Solution to Detect and Prevent Delirium


Share this article
Share this article
HAIFA, Israel, Jan. 19, 2021 /PRNewswire/ -- MindUP, Israel's first dedicated digital health incubator, is pleased to welcome CogMe to its family of portfolio companies.
CogMe is developing a platform to reduce cognitive drops in populations at risk, initially focusing on delirium, an acute condition that most commonly arises in an inpatient setting. Using AI, CogMe will provide a comprehensive solution that will analyze cognitive and biological indicators of the individual patient to predict, detect and intervene to prevent cognitive drops.
"Delirium, a prevalent and dangerous sudden state of confusion common in elderly adults, is nearly universally under-recognized and under-treated," noted Liat Feinberg, CEO and co-founder of CogMe. "It often leads to a cascade of events that include patient falls, further complications, extended post-acute care and even death. Naturally, these adverse events also increase the cost of care. We believe that early detection is the key to preventing this deterioration."

Related Keywords

Israel , Maura Rosenfeld , Ilan Ben Oren , Dan Shwarzman , Israel Innovation Authority , Ibm , Medtronic , Rambam Medical Center , Liat Feinberg , Pitango Venture Capital , Impact First Investments , Israel Innovation , Mind Up , இஸ்ரேல் , ம Ura ரா ரோஸெந்‌ஃபெல்ட் , இலன் பென் ஒரேன் , இஸ்ரேல் கண்டுபிடிப்பு அதிகாரம் , ஐபீயெம் , மெதிடிறோனிக் , தாக்கம் முதல் முதலீடுகள் , இஸ்ரேல் கண்டுபிடிப்பு ,

© 2025 Vimarsana